Results 201 to 210 of about 1,999,187 (315)
Statistical analysis plan for a stepped-wedge cluster randomized clinical trial for the evaluation of the clinical impact of different telemedicine practices in intensive care units - TELESCOPE 2 trial. [PDF]
Santos TMD +21 more
europepmc +1 more source
ABSTRACT Dunaliella species are among the most significant biological sources of carotenoids, notably beta‐carotene. Given that chemical synthesis offers a more cost‐effective alternative to biotechnological cultivation, optimizing production strategies is essential for economic viability.
Camylle Guimarães Scheliga +3 more
wiley +1 more source
First clinical-epidemiological profile of zoonotic sporotrichosis in a state capital of Northeast Brazil: evidence of an emerging feline-driven urban epidemic. [PDF]
Mendonça TD +8 more
europepmc +1 more source
A microelectrochemical analytical tool is proposed for the accelerated evaluation of the intrinsic electrochemical performance of Prussian‐blue analogues as solid active materials in Na+‐based batteries. By confining the solid active material inside a recessed microelectrode, accelerated voltammetric and galvanostatic cycling at high C‐rate become ...
Nomnotho Jiyane +9 more
wiley +1 more source
Expression of Concern: Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats. [PDF]
Bomfim GF +8 more
europepmc +1 more source
Abstract Tree bark remains an underexploited source of high‐value‐added phenolic compounds with potential circular bioeconomy applications. This work characterized bark extracts from two species of distinct Brazilian biomes, Stryphnodendron adstringens (Cerrado) and Myrcia eximia (Amazon), obtained with three solvents (ethanol, methanol and acetone ...
Mário Sérgio Lorenço +7 more
wiley +1 more source
Influence of eccentric tempo on concentric performance in competitive Paralympic bench press. [PDF]
Luz Dos Santos A +8 more
europepmc +1 more source
Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley +1 more source

